1. Home
  2. BODI vs NEPH Comparison

BODI vs NEPH Comparison

Compare BODI & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Beachbody Company Inc.

BODI

The Beachbody Company Inc.

HOLD

Current Price

$11.75

Market Cap

71.2M

Sector

Industrials

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$4.43

Market Cap

60.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BODI
NEPH
Founded
1998
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.2M
60.0M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
BODI
NEPH
Price
$11.75
$4.43
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$8.00
$6.00
AVG Volume (30 Days)
49.3K
53.1K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
$282,565,000.00
$17,930,000.00
Revenue This Year
N/A
$33.32
Revenue Next Year
N/A
$12.27
P/E Ratio
N/A
$32.34
Revenue Growth
N/A
32.36
52 Week Low
$3.38
$1.39
52 Week High
$12.33
$6.42

Technical Indicators

Market Signals
Indicator
BODI
NEPH
Relative Strength Index (RSI) 60.90 46.23
Support Level $10.03 $4.31
Resistance Level $10.97 $4.82
Average True Range (ATR) 0.77 0.32
MACD 0.10 -0.01
Stochastic Oscillator 88.08 36.47

Price Performance

Historical Comparison
BODI
NEPH

About BODI The Beachbody Company Inc.

The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: